Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Monti G, Giovannini G, Marudi A, Bedin R, et al. Seizure 2020;81:18-20.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Monti G, Giovannini G, Marudi A, Bedin R, et al. Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. Seizure 2020;81:18-20.
PMID: 32688169